These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21908190)

  • 61. Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1).
    Wang H; Robl JA; Hamann LG; Simpkins L; Golla R; Li YX; Seethala R; Zvyaga T; Gordon DA; Li JJ
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4146-9. PubMed ID: 21689935
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.
    Smaill JB; Palmer BD; Rewcastle GW; Denny WA; McNamara DJ; Dobrusin EM; Bridges AJ; Zhou H; Showalter HD; Winters RT; Leopold WR; Fry DW; Nelson JM; Slintak V; Elliot WL; Roberts BJ; Vincent PW; Patmore SJ
    J Med Chem; 1999 May; 42(10):1803-15. PubMed ID: 10346932
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK.
    Waelchli R; Bollbuck B; Bruns C; Buhl T; Eder J; Feifel R; Hersperger R; Janser P; Revesz L; Zerwes HG; Schlapbach A
    Bioorg Med Chem Lett; 2006 Jan; 16(1):108-12. PubMed ID: 16236504
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Design and synthesis of novel spirocyclic carboxylic acids as potent and orally bioavailable DGAT1 inhibitors and their biological evaluation.
    Koul S; Kurhade S; Bhosale S; Naik K; Salunkhe V; Ravula S; Punde P; Velayutham R; Tiwari A; Ahl D; Malkapuram S; Mudagala V; Raje A; Umrani D; Tambe S; Patil P; Singh U; Bhuniya D; Hariharan N; Mookhtiar K
    Bioorg Med Chem Lett; 2022 Apr; 62():128632. PubMed ID: 35189320
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Discovery of diamide compounds as diacylglycerol acyltransferase 1 (DGAT1) inhibitors.
    Nakajima K; April M; Brewer JT; Daniels T; Forster CJ; Gilmore TA; Jain M; Kanter A; Kwak Y; Li J; McQuire L; Serrano-Wu MH; Streeper R; Szklennik P; Thompson J; Wang B
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1245-8. PubMed ID: 26804232
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis and biological evaluation of isoxazole, oxazole, and oxadiazole containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors.
    Jadhav RD; Kadam KS; Kandre S; Guha T; Reddy MM; Brahma MK; Deshmukh NJ; Dixit A; Doshi L; Potdar N; Enose AA; Vishwakarma RA; Sivaramakrishnan H; Srinivasan S; Nemmani KV; Gupte A; Gangopadhyay AK; Sharma R
    Eur J Med Chem; 2012 Aug; 54():324-42. PubMed ID: 22683241
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of diacylglycerol acyltransferase inhibitors from Rosa centifolia petals.
    Kondo H; Hashizume K; Shibuya Y; Hase T; Murase T
    Lipids; 2011 Aug; 46(8):691-700. PubMed ID: 21538210
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Development of a series of aryl pyrimidine kynurenine monooxygenase inhibitors as potential therapeutic agents for the treatment of Huntington's disease.
    Toledo-Sherman LM; Prime ME; Mrzljak L; Beconi MG; Beresford A; Brookfield FA; Brown CJ; Cardaun I; Courtney SM; Dijkman U; Hamelin-Flegg E; Johnson PD; Kempf V; Lyons K; Matthews K; Mitchell WL; O'Connell C; Pena P; Powell K; Rassoulpour A; Reed L; Reindl W; Selvaratnam S; Friley WW; Weddell DA; Went NE; Wheelan P; Winkler C; Winkler D; Wityak J; Yarnold CJ; Yates D; Munoz-Sanjuan I; Dominguez C
    J Med Chem; 2015 Feb; 58(3):1159-83. PubMed ID: 25590515
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis and glycosidase inhibitory profiles of functionalised morpholines and oxazepanes.
    Burland PA; Osborn HM; Turkson A
    Bioorg Med Chem; 2011 Sep; 19(18):5679-92. PubMed ID: 21862336
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.
    Traxler PM; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
    J Med Chem; 1996 Jun; 39(12):2285-92. PubMed ID: 8691423
    [TBL] [Abstract][Full Text] [Related]  

  • 71. New potential inhibitors of cyclin-dependent kinase 4: design and synthesis of pyrido[2,3-d]pyrimidine derivatives under microwave irradiation.
    Tu S; Zhang J; Zhu X; Xu J; Zhang Y; Wang Q; Jia R; Jiang B; Zhang J
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3578-81. PubMed ID: 16621547
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synthesis of sydnone substituted Biginelli derivatives as hyaluronidase inhibitors.
    Gireesh T; Kamble RR; Kattimani PP; Dorababu A; Manikantha M; Hoskeri JH
    Arch Pharm (Weinheim); 2013 Sep; 346(9):645-53. PubMed ID: 23908008
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Discovery of 2-(2-chlorophenyl)-3-(4-chlorophenyl)-7-(2,2-difluoropropyl)-6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8(5H)-one (PF-514273), a novel, bicyclic lactam-based cannabinoid-1 receptor antagonist for the treatment of obesity.
    Dow RL; Carpino PA; Hadcock JR; Black SC; Iredale PA; DaSilva-Jardine P; Schneider SR; Paight ES; Griffith DA; Scott DO; O'Connor RE; Nduaka CI
    J Med Chem; 2009 May; 52(9):2652-5. PubMed ID: 19351113
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Discovery of dimethyl pent-4-ynoic acid derivatives, as potent and orally bioavailable DGAT1 inhibitors that suppress body weight in diet-induced mouse obesity model.
    Yu T; Wu C; Shih N; Li Q; Chan C; Pan H; Yao D; Pan Y; Liang W; Shen L; Zhao H; Li J; Chen S
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1686-1692. PubMed ID: 29699923
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and structure-activity relationship of aminopyrimidine IKK2 inhibitors.
    Bingham AH; Davenport RJ; Fosbeary R; Gowers L; Knight RL; Lowe C; Owen DA; Parry DM; Pitt WR
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3622-7. PubMed ID: 18501602
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors.
    Ibrahim DA; El-Metwally AM
    Eur J Med Chem; 2010 Mar; 45(3):1158-66. PubMed ID: 20045222
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of 2-aminooxazole amides as acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) inhibitors through scaffold hopping strategy.
    Kim HM; Smith MD; Kim JH; Caplen MA; Chan TY; McKittrick BA; Cook JA; van Heek M; Lachowicz J
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6410-4. PubMed ID: 24120540
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Synthesis and structure-activity relationship of fused-pyrimidine derivatives as a series of novel GPR119 agonists.
    Negoro K; Yonetoku Y; Moritomo A; Hayakawa M; Iikubo K; Yoshida S; Takeuchi M; Ohta M
    Bioorg Med Chem; 2012 Nov; 20(21):6442-51. PubMed ID: 23010456
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Coenzyme A: diacylglycerol acyltransferase 1 inhibitor ameliorates obesity, liver steatosis, and lipid metabolism abnormality in KKAy mice fed high-fat or high-carbohydrate diets.
    Yamamoto T; Yamaguchi H; Miki H; Shimada M; Nakada Y; Ogino M; Asano K; Aoki K; Tamura N; Masago M; Kato K
    Eur J Pharmacol; 2010 Aug; 640(1-3):243-9. PubMed ID: 20478303
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors.
    Song X; Chen W; Lin L; Ruiz CH; Cameron MD; Duckett DR; Kamenecka TM
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7072-5. PubMed ID: 22004719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.